Tomasz Schneider

Summary

Affiliation: King's College London
Country: UK

Publications

  1. ncbi Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism
    Tomasz Schneider
    Department of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, , Poland
    Neuropsychopharmacology 30:80-9. 2005
  2. ncbi Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants
    Tomasz Schneider
    Behavioral Neuroscience, Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna Street, 31 343 Krakow, Poland
    Psychoneuroendocrinology 32:651-9. 2007
  3. ncbi Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid
    Tomasz Schneider
    Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna Str, 31 343 Krakow, Poland
    Psychoneuroendocrinology 33:728-40. 2008
  4. ncbi Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism
    Tomasz Schneider
    Department of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, , Poland
    Neuropsychopharmacology 31:36-46. 2006
  5. ncbi An animal model of premenstrual dysphoric disorder sensitive to antidepressants
    Tomasz Schneider
    Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland
    Curr Protoc Neurosci . 2009
  6. ncbi Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism
    Tomasz Schneider
    Department of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland
    Psychopharmacology (Berl) 193:547-55. 2007
  7. ncbi Increased depressive-like traits in an animal model of premenstrual irritability
    Tomasz Schneider
    Behavioral Neuroscience, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland
    Horm Behav 51:142-8. 2007

Detail Information

Publications7

  1. ncbi Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism
    Tomasz Schneider
    Department of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, , Poland
    Neuropsychopharmacology 30:80-9. 2005
    ..Our results bring further support to validity of the proposed VPA animal model of autism, suggesting similarities between the observed pattern of behavioral alterations in VPA rats and features of disturbed behavior in autistic patients...
  2. ncbi Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants
    Tomasz Schneider
    Behavioral Neuroscience, Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna Street, 31 343 Krakow, Poland
    Psychoneuroendocrinology 32:651-9. 2007
    ..This manifestation may be used to elucidate the neuroendocrine mechanisms triggering premenstrual irritability, and the detailed mode of action of antidepressants when used for PMDD...
  3. ncbi Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid
    Tomasz Schneider
    Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna Str, 31 343 Krakow, Poland
    Psychoneuroendocrinology 33:728-40. 2008
    ....
  4. ncbi Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism
    Tomasz Schneider
    Department of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, , Poland
    Neuropsychopharmacology 31:36-46. 2006
    ..These results suggest that postnatal environmental manipulations can counteract the behavioral alterations in VPA rats. We propose environmental enrichment as an important tool for the treatment of autism spectrum disorders...
  5. ncbi An animal model of premenstrual dysphoric disorder sensitive to antidepressants
    Tomasz Schneider
    Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland
    Curr Protoc Neurosci . 2009
    ..This model may be used to study the neuroendocrine mechanisms triggering premenstrual irritability, and the mode of action of antidepressants used for the treatment of PMDD...
  6. ncbi Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism
    Tomasz Schneider
    Department of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland
    Psychopharmacology (Berl) 193:547-55. 2007
    ..Many of those aberrations have been recently modeled in rats exposed to valproic acid (VPA) on the 12th day of gestation (VPA rats)...
  7. ncbi Increased depressive-like traits in an animal model of premenstrual irritability
    Tomasz Schneider
    Behavioral Neuroscience, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland
    Horm Behav 51:142-8. 2007
    ..This phenomenon could potentially aid the elucidation of premenstrual emotional dysfunctions and might be used as an ethological model to study a biochemical and genetic proneness to depression...